Cargando…
An introduction to therapeutic approaches to vascular cognitive impairment
Vascular cognitive impairment (VCI), encompassing vascular dementia, has been claimed as the “second-most common dementia” after Alzheimer Disease. Whether or not this is true, the clinical picture of most dementia in older people includes vascular disease. There are no validated pharmacological tar...
Autores principales: | Hainsworth, Atticus H, Elahi, Fanny M, Corriveau, Roderick A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8661126/ https://www.ncbi.nlm.nih.gov/pubmed/34950896 http://dx.doi.org/10.1016/j.cccb.2021.100033 |
Ejemplares similares
-
Clinical trials in vascular cognitive impairment following SPRINT-MIND: An international perspective
por: Elahi, Fanny M., et al.
Publicado: (2023) -
Vascular cognitive impairment and dementia: An early career researcher perspective
por: Silva, Nárlon C. Boa Sorte, et al.
Publicado: (2022) -
PDE5 inhibitor drugs for use in dementia
por: Hainsworth, Atticus H., et al.
Publicado: (2023) -
The PASTIS trial: Testing tadalafil for possible use in vascular cognitive impairment
por: Pauls, Mathilde M.H., et al.
Publicado: (2022) -
Translational models for vascular cognitive impairment: a review including larger species
por: Hainsworth, Atticus H., et al.
Publicado: (2017)